| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.0M | -47.6% | +37.6% |
| R&D Expense | $55.0M | +40.3% | +34.3% |
| SG&A Expense | $22.1M | +0.3% | +15.2% |
| Operating Income | -$76.3M | -53.8% | +18.6% |
| Pre-tax Income | -$68.8M | -89.2% | -9.8% |
| Income Tax | -$11.6M | -620.4% | -1.1% |
| Net Income | -$57.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $83.2M | -10.0% | -34.3% |
| Accounts Receivable | $71.2M | +1.8% | — |
| Current Assets | $695.1M | -6.3% | -6.4% |
| Total Assets | $1.36B | -3.3% | -2.6% |
| Current Liabilities | $68.8M | +2.7% | -13.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$96.6M | — | — |
| Capital Expenditures | $32.9M | — | — |
| Investing Cash Flow | $12.6M | — | — |
| Financing Cash Flow | $10.0M | — | — |
| Free Cash Flow | -$129.5M | — | — |
| -64.5% |
| -11.8% |
| EPS (Basic) | -$0.19 | -58.3% | -11.8% |
| EPS (Diluted) | -$0.19 | -58.3% | -11.8% |
| $392.0M |
| -0.8% |
| +24.5% |
| Stockholders' Equity | $964.0M | -4.3% | -10.6% |